Skip to main content
Log in

Monolithic Osmotic Tablets for Controlled Delivery of Antihypertensive Drug

  •  
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

An oral monolithic osmotically controlled delivery system for nifedipine using asymmetric membrane technology was developed and evaluated. Unlike conventional osmotic systems, which require laser drilling, this system releases the drug in a controlled manner from asymmetric membrane coated core tablets. Asymmetric membrane is formed by dry process with phase inversion technology process using cellulose acetate as the coating material. Higher water influx of this membrane aids in delivery of nifedipine, which is highly water insoluble with low osmotic pressure. The porous structure of the membrane was confirmed by scanning electron microscopy. Influence of different osmotic agents on drug release was evaluated. In vitro release studies showed that as concentration of osmotic agents was increased, the drug release was also enhanced. Drug release from the developed monolithic system was independent of external agitation and pH of dissolution media. Comparative in vitro release data was obtained using different types of coating membranes like controlled porosity membrane and dense coating membrane with mechanically drilled orifice. Osmotic pressure generated in the system was determined using freezing point osmometer. The osmotic pressure developed was found to be linearly proportional to time and concentration of osmotic agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Santus G, Baker RW. Osmotic drug delivery: a review of the patent literature. J Control Release. 1995;35:1–21.

    Article  CAS  Google Scholar 

  2. Theeuwes F. Elementary osmotic pump. J Pharm Sci. 1975;64:1987–91.

    Article  PubMed  CAS  Google Scholar 

  3. Garg S, Verma RK, Krishna DM. Formulation aspects in the development of osmotically controlled oral delivery systems. J Control Release. 2002;79:7–27.

    Article  PubMed  Google Scholar 

  4. Liu L, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Control Release. 2000;67:309–22.

    Article  PubMed  CAS  Google Scholar 

  5. Herbig SM, Cardinal JR, Korsmeyer RW, Smith KL. Asymmetric-membrane tablet coatings for osmotic drug delivery. J Control Release. 1995;35:127–36.

    Article  CAS  Google Scholar 

  6. Chidlaw MB, Herbig SN, Korsmeyer RW. Osmotic drug delivery from asymmetric membrane film-coated dosage forms. In: Wise DL, editor. Handbook of pharmaceutical controlled release technology. New York: Marcel Dekker; 2000. p. 751–85.

    Google Scholar 

  7. Fiesen E, Hagen TA. Preformulation. In: Lachman L, Lieberman HA, Kanig JL, editors. Theory and practice of industrial pharmacy. Philadelphia: Lea and Febiger; 1991. p. 312–5.

    Google Scholar 

  8. Rudnic E, Schwartz JB. Oral solid dosage forms. In: Hoover JE, editor. Remington’s pharmaceutical sciences. Easton: Mack; 1980. p. 1633–65.

    Google Scholar 

  9. Schwartz JW, Connors RE, Schnaare RL. Optimization techniques in pharmaceutical formulation and processing. In: Banker GS, Rhodes CT, editors. Modern pharmaceutics (Drugs and the pharmaceutical Sciences series). Marcel Dekker: Philadelphia; 2002. p. 607–26.

    Google Scholar 

  10. Grundy JS, Anderson KE, Rogers JA, Foster RT. Studies on dissolution testing of the nifedipine gastrointestinal therapeutic system. I. Description of a two-phase in vitro test. J Control Release. 1997;48:1–8.

    Article  CAS  Google Scholar 

  11. Liu X, Chen D, Zhang R. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo. Drug Develop Ind Pharm. 2003;29:813–9.

    Article  CAS  Google Scholar 

  12. Lu EX, Zhi-Jiang ZQ. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J Control Release. 2000;92:375–82.

    Article  Google Scholar 

  13. Thombre AG, Appel LE, Chidlaw MB. Osmotic drug delivery using swellable-core technology. J Control Release. 2004;94:75–89.

    Article  PubMed  CAS  Google Scholar 

  14. Cardinal JR, Herbig SM, Korsmeyer RW, Smith KL, Thombre AG. Use of asymmetric membranes in delivery devices US Patent 5612059 1997.

  15. Makhija SN, Vavia PR. CPOP-based controlled release systems for psedoephedrine-I, cellulose acetate as a semipermeable membrane. J Control Release. 2003;89:5–18.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

The authors are thankful to Sekhsaria Chemicals Pvt. Ltd. for support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amrita Bajaj.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhanushali, R., Wakode, R. & Bajaj, A. Monolithic Osmotic Tablets for Controlled Delivery of Antihypertensive Drug. J Pharm Innov 4, 63–70 (2009). https://doi.org/10.1007/s12247-009-9055-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-009-9055-5

Keywords

Navigation